Friday, February 10, 2017 8:39:05 PM
I agree in that it is a very good thing that AC5 is being classified as a device vs. drug as Trump has vocalized his displeasure w/ pharma prices. I've unfortunately spent too much time lately wondering what will come from the New Administration next. While I think that Arch and AC5 are safe, the unknown is a little more real than if the opposing party had won the presidency. A lot going on. A lot to absorb. While it is interesting, you always have to wonder how your #1 pick plays out. Good luck to all of you.
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM